M4MM
New Zealand Approves Psilocybin for Medicinal Use
LOS ANGELES— New Zealand’s government has authorized the prescription of psilocybin, the psychoactive compound found in so‑called “magic mushrooms,” for patients with treatment‑resistant depression. This marks the first time psilocybin has been approved for medical use ...
Psyence Group Inc. Announces C$600,000 Private Share Offering
LOS ANGELES— Psyence Group Inc. a biotechnology firm focused on nature-derived psilocybin for mental health and palliative care, has announced a non-brokered private placement to raise up to C$600,000. The offering, detailed in a news ...
Texas Governor Expands Medical Cannabis Program, Vetoes THC Ban
LOS ANGELES— Texas Governor Greg Abbott has signed House Bill 46 into law, significantly expanding the state’s limited medical cannabis program, while vetoing Senate Bill 3, which aimed to ban hemp‑derived THC products—including delta‑8 gummies, ...
Idaho House Advances Bill Imposing $300 Minimum Fine for Cannabis Possession
LOS ANGELES- The Idaho House of Representatives has passed House Bill 7, which mandates a minimum fine of $300 for adults convicted of possessing three ounces or less of cannabis. Rep. Bruce Skaug (R-Nampa) introduced ...
Canada Invests Nearly $3 Million in Psilocybin-Assisted Psychotherapy Research
LOS ANGELES- The Government of Canada, through the Canadian Institutes of Health Research (CIHR), has committed nearly $3 million to fund three clinical trials investigating psilocybin-assisted psychotherapy as a treatment for various mental health and ...
Cybin Announces Third Quarter Fiscal Year 2025 Financial Results and Business Updates
LOS ANGELES- Cybin Inc., has released its unaudited financial results for the third quarter ending December 31, 2024, alongside recent business developments. Financial Highlights: Cash Position: As of December 31, 2024, Cybin reported cash holdings ...
Montana Lawmaker Proposes Consumer Registration and Surveillance for Cannabis Purchases
LOS ANGELES- A Republican lawmaker in Montana has introduced legislation that would require individuals aged 21 and older to register with the state Department of Revenue and pay a $200 annual fee to legally purchase ...
New Zealand Approves Psilocybin for Medicinal Use
LOS ANGELES— New Zealand’s government has authorized the prescription of psilocybin, the psychoactive compound found in so‑called “magic mushrooms,” for patients with treatment‑resistant depression. This marks the first time psilocybin has been approved for medical use ...
Psyence Group Inc. Announces C$600,000 Private Share Offering
LOS ANGELES— Psyence Group Inc. a biotechnology firm focused on nature-derived psilocybin for mental health and palliative care, has announced a non-brokered private placement to raise up to C$600,000. The offering, detailed in a news ...
Texas Governor Expands Medical Cannabis Program, Vetoes THC Ban
LOS ANGELES— Texas Governor Greg Abbott has signed House Bill 46 into law, significantly expanding the state’s limited medical cannabis program, while vetoing Senate Bill 3, which aimed to ban hemp‑derived THC products—including delta‑8 gummies, ...
Portable Cannabis Vaporizers Market is Set to Touch US$ 14 Billion valuation by 2031
Seoul, South Korea - The global cannabis vaporizer market is projected to expand 3.5X its value from 2021 to 2031, with demand for temperature-controlled cannabis vaporizers rising as the years go by. The importance of ...
MariMed’s Nature’s Heritage Brand Sponsors Cultivators Cup
NORWOOD, Mass. - MariMed, Inc. (CSE: MRMD), (OTCQX: MRMD), a multi-state cannabis operator, announced its Nature’s Heritage brand of craft flower and concentrates is a Presenting Sponsor of Cultivators Cup, the leading cannabis industry festival ...
Ayr Wellness Receives Key Massachusetts Regulatory Approval for Adult-Use Sales in Somerville
MIAMI - Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF), a multi-state cannabis operator, announced that the Massachusetts Cannabis Control Commission (“CCC” or the “Commission”) has granted a final license for adult-use cannabis at its Sira ...
Clever Leaves Reports Second Quarter 2022 Results
BOCA RATON, Fla. - Clever Leaves Holdings Inc. (Nasdaq: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, is reporting financial and operating results for the second ...
Trulieve Delivers Record Second Quarter 2022 Results Driven by Organic Retail Sales
TALLAHASSEE-- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), a cannabis company in the U.S., today announced its results for the quarter ended June 30, 2022. Results are reported in U.S. dollars unless otherwise indicated. Q2 2022 Financial Highlights* ...
Jamie Pearson to Step Down as Bhang President/CEO and Director
LAS VEGAS- Bhang Inc. (CSE:BHNG) (OTCQB:BHNGF) ("Bhang" or the "Company") has announced the resignation of President, CEO, and Board Member, Jamie L. Pearson, who has been with the Company since 2015 and has served as President/CEO ...
Akerna Announces Financial Results for Second Quarter 2022
DENVER - Akerna (Nasdaq: KERN), an enterprise software company and developer of one of the most comprehensive technology infrastructures, ecosystems, and compliance engines powering the global cannabis industry, today reported its unaudited financial results for ...
Global Medicinal Cannabis Market to Surpass US$ 58MM by 2030
SEATTLE- According to Coherent Market Insights, the global medicinal cannabis market is estimated to be valued at US$ 10,180.17 Million in 2022 and is expected to exhibit a CAGR of 24.4 % during the forecast ...
Verano Releases Signature Reserve and Essence Branded Product Lines in Four Additional Core Cannabis Markets
CHICAGO - Verano™ Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF), a multi-state cannabis company, today announced the Company now offers its namesake Verano signature flower branded products in four new core markets: Arizona, Florida, Massachusetts and ...
Cronos Group Reports 2022 Second Quarter Results
TORONTO - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON), announces its 2022 second quarter business results. “I am encouraged by the progress we are making to realign our business around our brands to become more ...
Medical Marijuana Market Worth USD 248.42 Billion by 2030 at 31.97% CAGR
New York, USA - Medical Marijuana Market Overview - According to a Comprehensive Research Report by Market Research Future (MRFR), “Medical Marijuana Market Information By Product Type, Application, Distribution, And Region - Forecast till 2030", ...
Curaleaf Announces Majority Stake and Forms Strategic Partnership with Germany’s Four 20 Pharma
WAKEFIELD, Mass.- Curaleaf Holdings, Inc. announced that Curaleaf International Holdings Limited, the company's European holding company, has signed a definitive agreement to acquire a 55% stake in Four 20 Pharma GmbH, a EU-GMP & GDP ...
Charlotte’s Web Engages Hanson Faso Sales and Marketing, Inc. for the Central United States
DENVER - (TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc., is expanding in the central United States in partnership with Hanson Faso Sales and Marketing Inc., brokers in the sales and marketing of specialty, natural, ...
Jushi Holdings Inc. Settles Lawsuit with Large Multi-State Operator
BOCA RATON, Fla., - Jushi Holdings Inc. (CSE: JUSH) (OTCQX: JUSHF), a multi-state cannabis operator, announced that it entered into a confidential settlement agreement with Curaleaf Holdings, Inc. and with Jushi’s former Chief Financial Officer, ...
MariMed Reports Second Quarter 2022 Earnings
NORWOOD - MariMed, Inc. (CSE: MRMD) (OTCQX: MRMD), a multi-state cannabis operator focused on improving lives every day, today announced its financial results for the second quarter ended June 30, 2022. “We executed on our ...
